Search Results

There are 1433 results for: content related to: Osteonecrosis of the jaws associated with the use of yearly zoledronic acid: Report of 2 cases

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >
  1. You have full text access to this OnlineOpen article
    Final 5-year results of Z-FAST trial

    Cancer

    Volume 118, Issue 5, 1 March 2012, Pages: 1192–1201, Adam M. Brufsky, W. Graydon Harker, J. Thaddeus Beck, Linda Bosserman, Charles Vogel, Christopher Seidler, Lixian Jin, Ghulam Warsi, Eliza Argonza-Aviles, John Hohneker, Solveig G. Ericson and Edith A. Perez

    Article first published online : 10 OCT 2011, DOI: 10.1002/cncr.26313

  2. The Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Varying Degrees of Renal Function

    The Journal of Clinical Pharmacology

    Volume 43, Issue 2, February 2003, Pages: 154–162, Dr. Andrej Skerjanec, Dr. James Berenson, Dr. ChyiHung Hsu, Dr. Pierre Major, Dr. Wilson H. Miller Jr., Ms. Christina Ravera, Dr. Horst Schran, Dr. John Seaman and Dr. Felix Waldmeier

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270002239824

  3. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells

    Cell Biology International

    Volume 33, Issue 2, February 2009, Pages: 239–246, B. Karabulut, C. Erten, M.K. Gul, E. Cengiz, B. Karaca, Y. Kucukzeybek, G. Gorumlu, H. Atmaca, S. Uzunoglu, U.A. Sanli, Y. Baran and R. Uslu

    Article first published online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2008.11.011

  4. Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastasis from Solid Tumor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 3, March 2012, Pages: 274–284, Maryam Iranikhah, Teresa W. Wilborn, Terri M. Wensel and Jodi B. Ferrell

    Article first published online : 13 FEB 2012, DOI: 10.1002/j.1875-9114.2011.01092.x

  5. You have full text access to this OnlineOpen article
    Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis

    BJU International

    Volume 109, Issue 3, February 2012, Pages: 394–400, Kouji Izumi, Atsushi Mizokami, Shingo Itai, Takashi Shima, Kazuyoshi Shigehara, Sotaro Miwa, Yuji Maeda, Hiroyuki Konaka, Eitetsu Koh and Mikio Namiki

    Article first published online : 23 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10192.x

  6. Bisphosphonates and other bone agents for breast cancer

    Intervention Review

    The Cochrane Library

    Matthew HF Wong, Martin R Stockler and Nick Pavlakis

    Published Online : 15 FEB 2012, DOI: 10.1002/14651858.CD003474.pub3

  7. You have full text access to this OnlineOpen article
    A single infusion of zoledronic acid produces sustained remissions in paget disease: Data to 6.5 years

    Journal of Bone and Mineral Research

    Volume 26, Issue 9, September 2011, Pages: 2261–2270, Ian R Reid, Kenneth Lyles, Guoqin Su, Jacques P Brown, John P Walsh, Javier del Pino-Montes, Paul D Miller, William D Fraser, Susan Cafoncelli, Christina Bucci-Rechtweg and David J Hosking

    Article first published online : 19 AUG 2011, DOI: 10.1002/jbmr.438

  8. You have free access to this content
    Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

    Journal of Bone and Mineral Research

    Volume 26, Issue 3, March 2011, Pages: 503–511, Felicia Cosman, Erik Fink Eriksen, Chris Recknor, Paul D Miller, Núria Guañabens, Christian Kasperk, Philemon Papanastasiou, Aimee Readie, Hanumantha Rao, Jürg A Gasser, Christina Bucci-Rechtweg and Steven Boonen

    Article first published online : 18 FEB 2011, DOI: 10.1002/jbmr.238

  9. Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 10, November 2012, Pages: 788–792, S. Saracino, R. A. Canuto, M. Maggiora, M. Oraldi, M. Scoletta, L. Ciuffreda, A. M. Vandone, S. Carossa, M. Mozzati and G. Muzio

    Article first published online : 31 MAY 2012, DOI: 10.1111/j.1600-0714.2012.01173.x

  10. You have full text access to this OnlineOpen article
    Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial

    Journal of Bone and Mineral Research

    Volume 26, Issue 5, May 2011, Pages: 984–992, Jane A Cauley, Dennis Black, Steven Boonen, Steven R Cummings, Peter Mesenbrink, Lisa Palermo, Zulema Man, Peyman Hadji and Ian R Reid, on behalf of the HORIZON Pivotal Fracture Group

    Article first published online : 3 MAY 2011, DOI: 10.1002/jbmr.292

  11. The use of zoledronic acid in pediatric cancer patients

    Pediatric Blood & Cancer

    Volume 56, Issue 4, April 2011, Pages: 610–614, Keith J. August, Amanda Dalton, Howard M. Katzenstein, Bradley George, Thomas A. Olson, Karen Wasilewski-Masker and Louis B. Rapkin

    Article first published online : 23 DEC 2010, DOI: 10.1002/pbc.22681

  12. You have full text access to this OnlineOpen article
    Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases

    Cancer

    Volume 118, Issue 8, 15 April 2012, Pages: 2039–2047, Naoki Niikura, Jun Liu, Naoki Hayashi, Shana L. Palla, Yutaka Tokuda, Gabriel N. Hortobagyi, Naoto T. Ueno and Richard L. Theriault

    Article first published online : 2 DEC 2011, DOI: 10.1002/cncr.26512

  13. Differing effects of PTH 1–34, PTH 1–84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: An 18-month open-labeled observational study using HR-pQCT

    Journal of Bone and Mineral Research

    Volume 28, Issue 4, April 2013, Pages: 736–745, Stinus Hansen, Ellen M Hauge, Jens-Erik Beck Jensen and Kim Brixen

    Article first published online : 18 MAR 2013, DOI: 10.1002/jbmr.1784

  14. Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis

    Journal of Bone and Mineral Research

    Volume 27, Issue 7, July 2012, Pages: 1487–1493, Steven Boonen, Richard Eastell, Guoqin Su, Peter Mesenbrink, Felicia Cosman, Jane A Cauley, Ian R Reid, Frank Claessens, Dirk Vanderschueren, Kenneth W Lyles and Dennis M Black

    Article first published online : 15 JUN 2012, DOI: 10.1002/jbmr.1605

  15. The use of bisphosphonates in cancer treatment

    Annals of the New York Academy of Sciences

    Volume 1218, Issue 1, February 2011, Pages: 3–14, Robert Coleman

    Article first published online : 28 SEP 2010, DOI: 10.1111/j.1749-6632.2010.05766.x

  16. You have full text access to this OnlineOpen article
    Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model

    International Journal of Cancer

    Volume 126, Issue 2, 15 January 2010, Pages: 522–532, Penelope D. Ottewell, Diane V. Lefley, Simon S. Cross, C. Alyson Evans, Robert E. Coleman and Ingunn Holen

    Article first published online : 20 JUL 2009, DOI: 10.1002/ijc.24756

  17. Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma

    Hepatology Research

    Volume 40, Issue 12, December 2010, Pages: 1195–1203, Yoshio Katamura, Hiroshi Aikata, Yoshimasa Hashimoto, Yuki Kimura, Tomokazu Kawaoka, Shintaro Takaki, Koji Waki, Akira Hiramatsu, Yoshiiku Kawakami, Shoichi Takahashi, Masahiro Kenjo and Kazuaki Chayama

    Article first published online : 7 OCT 2010, DOI: 10.1111/j.1872-034X.2010.00729.x

  18. You have full text access to this OnlineOpen article
    ASBMR 31st Annual Meeting SU0001–SU0466

    Journal of Bone and Mineral Research

    Volume 24, Issue S1, 2009, Pages: S237–S369,

    Article first published online : 16 JUN 2011, DOI: 10.1002/jbmr.5650241304

  19. Pain outcomes in patients with advanced breast cancer and bone metastases

    Cancer

    Volume 119, Issue 4, 15 February 2013, Pages: 832–838, Charles S. Cleeland, Jean-Jacques Body, Alison Stopeck, Roger von Moos, Lesley Fallowfield, Susan D. Mathias, Donald L. Patrick, Mark Clemons, Katia Tonkin, Norikazu Masuda, Allan Lipton, Richard de Boer, Stefania Salvagni, Celia Tosello Oliveira, Yi Qian, Qi Jiang, Roger Dansey, Ada Braun and Karen Chung

    Article first published online : 5 SEP 2012, DOI: 10.1002/cncr.27789

  20. Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds – histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation

    Journal of Oral Pathology & Medicine

    Volume 41, Issue 9, October 2012, Pages: 702–712, Ana C. U. Vasconcelos, Soraya A. Berti-Couto, Alan A. Azambuja, Fernanda G. Salum, Maria A. Figueiredo, Vinícius D. da Silva and Karen Cherubini

    Article first published online : 14 MAR 2012, DOI: 10.1111/j.1600-0714.2012.01140.x

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >